Get the Stockscreener App
4.79
2.04%
-0.10
After Hours:
4.88
0.09
+1.88%
Goodrx Holdings Inc stock is traded at $4.79, with a volume of 661.82K.
It is down -2.04% in the last 24 hours and down -3.82% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.89
Open:
$4.87
24h Volume:
661.82K
Relative Volume:
0.45
Market Cap:
$480.44M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-36.12
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-3.62%
1M Performance:
-3.82%
6M Performance:
+0.42%
1Y Performance:
-47.07%
1-Day Range:
$4.78
$4.89
1-Week Range:
$4.78
$5.05
52-Week Range:
$3.675
$9.06
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.79 | 1.75B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
When is GoodRx Holdings Inc. stock expected to show significant growthStock Strategy Target Finder From AI Tools - jammulinksnews.com
What makes GoodRx Holdings Inc. stock price move sharplySwing Trading Entry Signals Suggest Opportunity Zone - beatles.ru
Published on: 2025-07-29 10:54:56 - metal.it
Amazon Pharmacy Veteran Defects to GoodRx: Inside the Strategic Executive Move Reshaping Digital Health - Stock Titan
How does GoodRx Holdings Inc. generate profit in a changing economyUnlock steady growth with low-risk stocks - jammulinksnews.com
What institutional investors are buying GoodRx Holdings Inc. stockExtraordinary performance - jammulinksnews.com
Why GoodRx Holdings Inc. stock attracts strong analyst attentionChart Breakout Alert - metal.it
What is the dividend policy of GoodRx Holdings Inc. stockMassive stock growth - jammulinksnews.com
What is GoodRx Holdings Inc. company’s growth strategyHigh-octane financial growth - jammulinksnews.com
What catalysts could drive GoodRx Holdings Inc. stock higher in 2025Access high-yield investment alerts now - jammulinksnews.com
What are the latest earnings results for GoodRx Holdings Inc.Consistently exceptional gains - jammulinksnews.com
Is GoodRx Holdings Inc. a good long term investmentOver 200% growth - PrintWeekIndia
GoodRx Holdings Inc. Stock Analysis and ForecastRapid capital growth - PrintWeekIndia
What drives GoodRx Holdings Inc. stock priceExceptional earning trajectories - PrintWeekIndia
Exploring High Growth Tech Stocks in the US This July 2025 - simplywall.st
What analysts say about GoodRx Holdings Inc. stockTriple-digit return opportunities - PrintWeekIndia
What institutions are buying GoodRx Holdings Inc. stock nowUnmatched profit potential - jammulinksnews.com
Jim Cramer Holds Back on GoodRx (GDRX) - MSN
Google, Meta Can't Escape GoodRx Health Data Sharing Suit - Law360
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc.GDRX - The Globe and Mail
Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - FinancialContent
Is GoodRx Holdings Inc. stock a good hedge against inflationChart Based Entries - Newser
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):